cysteine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

cysteine has been researched along with 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
El Fakhri, G; Habert, MO; Kas, A; Kijewski, MF; Lacomblez, L; Maksud, P; Malek, Z	1
Casteels, C; De Ceuninck, L; Dom, R; Maes, A; Mortelmans, L; Van Laere, K; Vanbilloen, B; Vandenberghe, W; Verbruggen, A	1
Hida, A; Kameyama, M; Morooka, M; Sato, K; Takeuchi, S	1
Cho, I; Chun, K; Kong, E	1

Trials

1 trial(s) available for cysteine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

Article	Year
Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:1 Topics: Cysteine; Diagnosis, Differential; Feasibility Studies; Female; Humans; Image Enhancement; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Parkinson Disease; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tropanes	2006

Article

Year

Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy.

European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:1

Topics: Cysteine; Diagnosis, Differential; Feasibility Studies; Female; Humans; Image Enhancement; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Parkinson Disease; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tropanes

2006

Other Studies

3 other study(ies) available for cysteine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

Article	Year
Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:3 Topics: Algorithms; Brain; Cysteine; Diagnosis, Differential; Discriminant Analysis; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Organotechnetium Compounds; Parkinson Disease; Pattern Recognition, Automated; Perfusion; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes	2006
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy. Clinical nuclear medicine, 2016, Volume: 41, Issue:6 Topics: 3-Iodobenzylguanidine; Brain; Chorea; Corpus Striatum; Cysteine; Diabetes Complications; Diabetes Mellitus; Dopamine; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neostriatum; Nortropanes; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon	2016
Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders. Medicine, 2021, Aug-27, Volume: 100, Issue:34 Topics: Aged; Brain; Cysteine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Organotechnetium Compounds; Parkinsonian Disorders; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tropanes	2021